Clinical Impact of New-Onset Left Bundle-Branch Block After Transcatheter Aortic Valve Implantation in the Japanese Population - A Single High-Volume Center Experience.


Journal

Circulation journal : official journal of the Japanese Circulation Society
ISSN: 1347-4820
Titre abrégé: Circ J
Pays: Japan
ID NLM: 101137683

Informations de publication

Date de publication:
25 05 2020
Historique:
pubmed: 1 4 2020
medline: 15 12 2020
entrez: 1 4 2020
Statut: ppublish

Résumé

Although left bundle-branch block (LBBB) is a known conduction disorder that occurs after transcatheter aortic valve implantation (TAVI), its clinical impact in the Japanese population remains unclear.Methods and Results:Of the 298 consecutive patients who underwent TAVI from January 2016 to December 2018 in a high-volume center in Japan, 68 with prior or periprocedural permanent pacemaker implantation (PPI), pre-existing LBBB, death during hospitalization, aborted procedure, or incomplete data were excluded. Among the final cohort of 230 patients, new-onset LBBB occurred in 90 (39%) after TAVI and persisted at 1-month follow up in 29 patients (13%; persistent new-onset LBBB, PN-LBBB). On multivariable analysis, self-expandable valve (SEV) use was found to be the only predictor of PN-LBBB (odds ratio: 4.39, 95% confidence interval: 1.69-11.41, P=0.002). There were no differences between patients with and without PN-LBBB in terms of overall mortality (18.8% vs. 26.0%, log-rank P=0.90) or need for late PPI (4.0% vs. 3.5%, log-rank P=0.74), yet there was an increased re-admission rate for heart failure (HF) in the PN-LBBB group (15.6% vs. 8.0%, log-rank P=0.046) at a median follow up of 431 (interquartile range, 271-733) days. PN-LBBB following TAVI was not associated with mortality or late PPI, but with a higher incidence of HF-related re-hospitalization at the mid-term follow up.

Sections du résumé

BACKGROUND
Although left bundle-branch block (LBBB) is a known conduction disorder that occurs after transcatheter aortic valve implantation (TAVI), its clinical impact in the Japanese population remains unclear.Methods and Results:Of the 298 consecutive patients who underwent TAVI from January 2016 to December 2018 in a high-volume center in Japan, 68 with prior or periprocedural permanent pacemaker implantation (PPI), pre-existing LBBB, death during hospitalization, aborted procedure, or incomplete data were excluded. Among the final cohort of 230 patients, new-onset LBBB occurred in 90 (39%) after TAVI and persisted at 1-month follow up in 29 patients (13%; persistent new-onset LBBB, PN-LBBB). On multivariable analysis, self-expandable valve (SEV) use was found to be the only predictor of PN-LBBB (odds ratio: 4.39, 95% confidence interval: 1.69-11.41, P=0.002). There were no differences between patients with and without PN-LBBB in terms of overall mortality (18.8% vs. 26.0%, log-rank P=0.90) or need for late PPI (4.0% vs. 3.5%, log-rank P=0.74), yet there was an increased re-admission rate for heart failure (HF) in the PN-LBBB group (15.6% vs. 8.0%, log-rank P=0.046) at a median follow up of 431 (interquartile range, 271-733) days.
CONCLUSIONS
PN-LBBB following TAVI was not associated with mortality or late PPI, but with a higher incidence of HF-related re-hospitalization at the mid-term follow up.

Identifiants

pubmed: 32224577
doi: 10.1253/circj.CJ-19-1071
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1012-1019

Commentaires et corrections

Type : CommentIn

Auteurs

Kenichi Sasaki (K)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Masaki Izumo (M)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Shingo Kuwata (S)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Yuki Ishibashi (Y)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Ryo Kamijima (R)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Mika Watanabe (M)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Toshiki Kaihara (T)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Kazuaki Okuyama (K)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Masashi Koga (M)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Haruka Nishikawa (H)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Yasuhiro Tanabe (Y)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Takumi Higuma (T)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Yoshihiro J Akashi (YJ)

Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH